|Bid||6.52 x 1100|
|Ask||9.55 x 1400|
|Day's Range||8.73 - 9.20|
|52 Week Range||8.44 - 43.26|
|Beta (5Y Monthly)||1.43|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Jonathan Moore, one of the first employees of Vertex Pharmaceuticals Inc. and a key scientist behind the company's renowned cystic fibrosis drugs, has a new venture called Rectify Pharmaceuticals.
There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although...
Rhythm Pharmaceuticals, Inc. (RYTM) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).